Hyundai Erdosetine Capsule

Adult dose

Adults: Administer 300 mg of erdosteine orally 2～3 times daily. When administered for acute respiratory disease, do not administer continuously for more than 10 days.

This medication should not be administered to certain patients. It should not be used in patients who are allergic to this drug or its components. In patients with liver cirrhosis or those with a deficiency in cystathionine synthase, this drug should not be administered as it may interfere with methionine metabolism. Patients with peptic ulcers should also avoid using this medication. This medication should not be given to patients with severe renal impairment, i.e., those with a creatinine clearance of less than 25 mL/min. The use of this medication is also prohibited in patients with severe hepatic impairment. In addition, it should be administered cautiously to patients with mild or moderate hepatic impairment, ensuring not to exceed 300 mg per day. Particularly in syrup formulations, caution is necessary for diabetic patients and those on low-calorie diets. This medication contains Yellow No. 5 dye, so it should be used with caution in patients who have an allergy or hypersensitivity to this dye. Overdosing may lead to symptoms such as sweating, dizziness, and facial flushing. Neurological and respiratory adverse reactions reported include headache, cold-like symptoms, and breathing difficulties. Gastrointestinal reactions may include taste disturbances, nausea, vomiting, diarrhea, abdominal pain, and heartburn. Skin reactions such as hives, erythema, and eczema may occur. When used with other cough medications, caution must be taken as it may lead to difficulty in expelling bronchial mucus, increasing the risk of bronchial infections and bronchial spasms. Pregnant or potentially pregnant women, as well as nursing mothers, are advised against using this medication as its safety has not been established. This medicine should be stored in a secure place out of reach of children, and transferring it to another container should be avoided as it may cause accidents or diminish the quality of the medication.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This medication should be taken with cough medicines only after consulting with a physician or pharmacist.

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius.

Appearance

A hard capsule with a green upper part and a yellowish lower part containing white powder.

Package unit

30 capsules/bottle, 300 capsules/bottle